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Abstract
Background: Preoperative determination of the aetiology of bile duct strictures at the hilum is difficult. We evaluated the
diagnostic accuracy of laboratory parameters and imaging modalities in differentiating between benign and malignant
causes of hilar biliary obstruction. Patients and methods: Fifty-eight patients (26 men) with a history of obstructive jaundice
and liver function tests (LFTs) and ultrasound suggestive of biliary obstruction at the hilum were studied. They were
evaluated by tumour marker assay (CA19-9), CT and MRI/MRCP. A single experienced radiologist, blinded to the results
of other tests, evaluated the imaging. The final diagnosis was made either from histology of the resected specimen, operative
findings or image-guided biopsy in inoperable patients. A receiver operator characteristic (ROC) curve was constructed for
each laboratory parameter to determine optimal diagnostic cut-off to predict malignant biliary stricture (MBS). Results: In
all, 34 patients had a benign and 24 had malignant aetiology. The mean age of benign patients was 38 years compared with
54 years for MBS. Forty-seven patients were treated with surgery while 11 had ERCP/PTC and stenting. The ROC curve
showed that preoperative bilirubin level8.4 mg/dl (sensitivity 83.3%, specificity 70%), alkaline phosphatase level478
IU (sensitivity 63%, specificity 49%) and CA19-9 levels100 U/L (sensitivity 45.8%, specificity 88.2%) for predicting
MBS. The sensitivity, specificity and diagnostic accuracy of MRI/MRCP (87.5%, 85.3%, 82.7%, respectively) was
marginally superior to CT (79.2%, 79.4%, 79.3%, respectively). Conclusions: Patients with a bilirubin level of8.4 mg%
and CA19-9 level100 U/L were more likely to have malignant aetiology. MRI/MRCP was a better imaging modality than
CT.
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Introduction
The differentiation of benign from malignant stric-
tures in the proximal bile duct is difficult [1,2].
Benign biliary tumours and strictures such as an
inflammatory stricture secondary to choledocholithia-
sis, Mirizzi syndrome, extrahepatic localized form of
primary sclerosing cholangitis (PSC) and idiopathic
benign focal stricture are the possible differential
diagnoses of a bile duct carcinoma [36]. The clinical
findings and laboratory values including tumour
marker levels are not specific enough to determine
the precise cause of a biliary stricture of the proximal
bile duct [79]. The accuracy of alkaline phosphatase
isoenzyme in differentiating benign from malignant
extrahepatic biliary obstruction has been reported to
be up to 80% [7]. CA19-9 has been used to
differentiate between cholangiocarcinoma and other
benign causes of obstruction, but it has a variable
sensitivity and specificity [10,11]. The radiological
modalities for evaluation of these patients include
ultrasonography, contrast-enhanced CT scan, MRI
and magnetic resonance cholangiopancreaticography
(MRCP). These non-invasive diagnostic methods
provide useful information about the level of obstruc-
tion, extent of biliary dilatation and the presence of a
mass or distant metastasis [1216]. Endoscopic
retrograde cholangiopancreatography (ERCP) and
percutaneous transhepatic cholangiography (PTC)
are more accurate imaging tests for bile duct evalua-
tion and allow a tissue diagnosis through brush biopsy
and cytology studies. However, these are associated
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with a significant risk of morbidity [17,18]. Moreover,
a preoperative histological assessment using biopsies
or brush cytology has limited sensitivity (3060%) in
spite of high specificity (95%) [19,20].
Hence, we carried out a study to identify the
diagnostic markers that help in differentiating a
benign from a malignant cause of proximal bile duct
stricture (within 2 cm of the confluence) using
laboratory tests and non-invasive imaging modalities
before planning surgery or an invasive interventional
procedure.
Patients and methods
Study design
This prospective study was conducted from October
2003 to August 2005. Fifty-four patients who at-
tended the GI surgery and gastroenterology out-
patient departments with a history suggestive of
obstructive jaundice underwent preliminary work-up
with liver function tests (LFTs) and an abdominal
ultrasound. Patients with liver function tests sugges-
tive of obstructive jaundice and an ultrasound show-
ing high biliary obstruction were included in the
study. High biliary obstruction was defined as ob-
struction to the normal flow of bile due to an extrinsic
or intrinsic block involving a biliary tract within 2 cm
of the confluence. Patients with a diagnosis of
carcinoma gall bladder with biliary obstruction, stric-
tured hepaticojejunostomy, portal biliopathy, hepatic
metastasis with biliary dilatation and hepatocellular
carcinoma with biliary dilatation were excluded from
the study, as the cause of hilar obstruction was
obvious. Patients assessed as being unfit to undergo
a major surgical procedure were also excluded.
These patients were then evaluated with a) bio-
chemical parameters (total bilirubin and alkaline
phosphatase); b) tumour marker (serum CA19-9);
c) imaging (contrast-enhanced helical computed to-
mography (CECT) and MRI with MRCP).
The whole abdomen was scanned with special
reference to the hepatobiliary and pancreatic region
by ultrasound using a Phillips HDI 3000/5000
scanner with a 3 MHz convex transducer after 6 h
of fasting in all patients.
CECT was performed in all patients using a
Somatom Plus-4 scanner (Siemens, Erlangen, Ger-
many). The patients were kept fasting for 6 h before
the procedure. Non-ionic iodinated contrast material
(20 ml in 750 ml of water) was given orally. Another
100 ml of contrast was injected into an antecubital
vein with a pressure injector at 3 ml/s. Helical CT was
performed with 5.0 mm thick collimation and a table
speed of 7.5 mm/s (1.5:1 pitch) for scanning from the
dome of the diaphragm to the third lumbar vertebra
and images were reconstructed at 5 mm intervals.
Immediately afterwards the rest of the abdomen and
pelvis were scanned with 10 mm collimation, 15 mm/s
table speed and 10 mm reconstruction interval.
MRI/MRCP was performed on a Siemens Sonata
Maestro class Magnetom 1.5 tesla MR scanner.
Phased array flexible torso coils were used. Before
MRCP, an axial T1W FLASH (TR/TE 104/4.8 ms:
flip angle 758, matrix 128256: scan time 18 s), axial
and coronal T2W TRUFISP (TR/TE 4.5/2.2 ms,
matrix 128256: scan time 18 s) and a heavily T2W
HASTE sequence (echo space of 10.9 ms, effective
TE 83 ms, one excitation, flip angle of 1508 and
matrix of 240256) were taken. Fat suppression was
used in some patients to suppress the signal from the
peritoneal fatty tissue. Axial and coronal thin (two to
four) sections were taken with HASTE sequence
through the entire biliary and pancreatic tree. This
was followed by a thick slab MRCP at slice thickness
of 3050 mm (imaging time 1.42 s) with careful
optimization of the slice position and orientation by
using axial T2-weighted images. The slab was placed
in such a manner that it did not include the renal
pelvis, spine and fluid in the duodenum or stomach.
Multiple angulations at increments of 108 were used
to achieve the best visualization of the biliary tree.
Negative contrast in the form of ferric ammonium
citrate 1200 mg dissolved in 70 ml of water was given
orally just before or during examination. The multi-
slice MRCP technique was used if satisfactory images
were not obtained by the thick slab single slice
method.
The parameters that were analysed included: a)
preoperative bilirubin level and serum alkaline phos-
phatase level; b) serum CA 19-9 level; c) CT findings
including any mass/thickening of the wall of the
common bile duct (CBD), lymph node1 cm and
atrophy-hypertrophy complex; and d) MRI/MRCP
findings including any thickening of the wall of the
CBD/mass, abrupt cut-off/gradual tapering, separa-
tion of ducts, length of the stricture and presence of
atrophy-hypertrophy complex.
Image analysis
CECT and MRI/MRCP were evaluated by a single
experienced radiologist. The radiologist was blinded
to the results of all other tests. Histopathology or
operative findings were considered as the gold stan-
dard. The final diagnosis was made either from
histology of the resected specimen and/or operative
findings, or image-guided biopsy in inoperable pa-
tients. In those patients where no tissue for histology
could be obtained, their subsequent clinical course
was used as the gold standard to ascertain whether
they had a benign or malignant cause for the
obstruction to the biliary tract. Any patient with
post-cholecystectomy biliary stricture, who had suspi-
cion of a malignancy at surgery, underwent a biopsy.
The classification of strictures into Bismuth type on
MRCP was compared with operative findings or
374 S.S. Saluja et al.
cholangiographic findings at ERC/PTC in inoperable
patients. The patency of the confluence on imaging
was compared with operative findings or cholangio-
graphic findings at ERC/PTC in inoperable patients.
Statistical analysis
Paired Student’s t test was used to compare contin-
uous variables. The x2 test was used for pair-wise
comparison of dichotomous variables. The sensitivity,
specificity, negative and positive predictive value and
diagnostic accuracy were used to compare the imaging
investigations. For all tests, a p valueB0.05 was
considered significant. The receiver operative char-
acteristic (ROC) curve was used to obtain the cut-off
values for laboratory parameters.
Results
Fifty-eight patients with a hilar block based on LFTs
and ultrasonography were included in the study. All
58 patients were evaluated with serum CA19-9 levels,
CT and MRCP.
Clinical features
The patients with malignant strictures were signifi-
cantly older compared with those with benign stric-
tures (pB0.001) and malignant strictures were seen
more frequently in men while benign strictures were
more common in women. The incidence of pain was
not significantly different between the two groups.
Anorexia and weight loss were significantly more
common in patients with malignant stricture (pB
0.001). Twenty-seven patients in the benign group
and seven patients in the malignant group had a
history of previous cholecystectomy. The demo-
graphic characteristics and laboratory parameters of
these patients are shown in Table I.
Laboratory parameters
The mean bilirubin levels and CA19-9 levels were
significantly higher in patients with malignant stric-
ture. The ROC analysis showed that a cut-off total
bilirubin level of 8.4 mg/dl (Figure 1) had a sensitivity
and specificity of 83% and 70%, respectively (area
under the curve0.807, SE0.051, 95% CI
0.6930.920) for diagnosing a malignant stricture.
The alkaline phosphatase level of 478 IU/L had a
sensitivity and specificity of 63% and 49% to detect
malignant strictures (Figure 1) and a CA19-9 level
of 100 IU/L had a sensitivity and a specificity of
45% and 88.2%, respectively (area under the
curve0.858, SE0.058, 95% CI0.7580.958)
(Figure 1).
Imaging
Ultrasonography showed biliary dilatation and cor-
rectly identified the level of obstruction in all patients.
Whether the confluence was blocked or not was
correctly ascertained in 22 of 24 patients with
malignant and in all patients with benign strictures
(compared with operative findings/cholangiographic
findings at ERC/PTC). Two patients with malignant
stricture had a blocked confluence, which on ultra-
sound was erroneously thought to be patent. Ultra-
sonography showed a mass lesion in 8 of 24 patients in
the malignant group and in 1 of 34 patients in the
benign group.
CT showed biliary dilatation in all the patients. The
confluence was patent in 23 patients with benign and
3 patients with malignant strictures. Of 24 patients
with malignant strictures, the gall bladder was col-
lapsed in 14, distended in 3 and the remaining 7 had a
history of cholecystectomy. In the benign group, 27
patients had a history of cholecystectomy while none
of the 7 patients without a previous cholecystectomy
had a distended gall bladder. Presence of mass and
enlarged lymph nodes on CT were significant findings
that helped in determining the nature of the stricture
(Table II). The presence of atrophy-hypertrophy
complex did not help in making the diagnosis. CT
provided additional information about the vascular
involvement in eight patients with malignant stric-
tures, thus helping in management. The images in
Figure 2a, b and c show the characteristics of benign
and malignant stricture seen on CT.
Of 34 patients with benign strictures, 27 patients
were correctly diagnosed on CT, while 7 patients were
incorrectly diagnosed because of the presence of a
mass alone (2 patients), lymphadenopathy alone (4
patients) and a mass associated with enlarged lymph
node (1 patient). Of 24 patients with a malignant
stricture, 19 were diagnosed correctly. Four patients
did not have any mass or enlarged lymph nodes, but
had either a history of previous cholecystectomy or
gallstones along with a patent confluence. One
patient, who was a known case of sarcoidosis, had a
stricture at the confluence with no mass and hence
was diagnosed to have a benign stricture. On follow-
up, he developed liver metastasis. The sensitivity of
Table I. Demographic data and laboratory parameters.
Parameter Benign Malignant p value
Mean age (years) 38914 5499 B0.001
Women 25 (73%) 7 (29%) 0.001
Men 9 (27%) 17 (71%) 0.001
Pain 27 (79%) 15 (62%) 0.15
Weight loss 13 (38%) 21 (87%) B0.001
Anorexia 13 (38%) 18 (75%) B0.001
Total bilirubin (mg/dl) 8.698.8 17.499.1 0.001
Alkaline phosphatase (IU/L) 5959393 8239569 0.98
SGOT (IU/L) 124984 113960 0.566
SGPT (IU/L) 92957 107991 0.482
CA19-9 (U/ml) 31961 1899267 0.009
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CT in predicting the nature of the stricture was
79.2%, specificity 79.4%, positive predictive value
73.1%, negative predictive value 84.4% and diagnos-
tic accuracy 79.3%.
The MRI/MRCP images were of good quality in all
patients. Both the intra- and extrahepatic biliary
radicals were visualized completely including the
proximal and distal extent of the stricture. The
confluence was patent in 23 and 3 patients with benign
and malignant stricture, respectively. The primary
confluence was involved in 5 patients while the
secondary confluence of either side was involved in
13 patients in the malignant group. Of 24 patients with
malignant strictures, gall bladder was collapsed in 14,
distended in 3 and absent in 7 patients. Atrophy-
hypertrophy complex did not differ significantly and
was seen in four and eight patients in the benign and
malignant group, respectively. The presence of a
mass and a stricture with an irregular margin, asym-
metric dilatation or long length had a significant
predictive value in determining the nature of the lesion
(Table III). Abrupt narrowing was present at a similar
frequency in both groups. The images shown in
Figure 3a, b and c show the characteristics of a
malignant stricture seen on MRI and MRCP.
Of 34 benign patients, 29 were correctly diagnosed
as having a benign stricture on MRI/MRCP, while 5
patients were diagnosed as having a malignant stric-
ture either because they had a mass (3 patients) or the
stricture morphology was suggestive of a malignant
stricture (5 patients). Of the three patients with
Mirrizzi’s syndrome, two were correctly diagnosed
on MRCP. The images in Figures 4 and 5 show
characteristics of a benign stricture and Mirrizzi
syndrome, respectively, seen on MRI and MRCP.
Of 24 patients with malignant stricture, 21 were
diagnosed correctly, 3 patients were diagnosed as
having a benign stricture as they had no mass and
the stricture morphology was suggestive of a benign
stricture. The sensitivity of MRCP for predicting the
nature of the stricture was 87.5%, specificity 85.3%,
positive predictive value 80.8%, negative predictive
value 90.6% and diagnostic accuracy 82.7%.
The comparison of Bismuth type of stricture on
MRCP with operative/ERC/PTC findings showed
that four patients with type 3 stricture were incorrectly
classified as type 2 and type 4 strictures in two
patients each in the benign group. In the remaining
25 patients the MRCP classification was in concor-
dance with the operative/ERC/PTC findings. While in
the malignant group three patients with type 2
stricture were incorrectly classified as type 1 (n1)
and type 3 (n2), one patient with type 3 stricture
was underestimated to have a type 2 stricture and one
patient with type 4 stricture was considered to have
type 3 stricture. The remaining 16 patients were
correctly classified by MRCP.
Management of patients
Based on the gold standard, there were 34 patients
with benign stricture and 24 patients with malignant
stricture (Table IV). All patients in the malignant
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Parameter Cut-off value Sensitivity (%) Specificity (%) p value
Total bilirubin (mg/dl) 8.4 83.3 70 <0.001
Alkaline phosphatase (IU/L) 478 63 49 0.11
CA19-9 (IU) 100 45.8 88.2 <0.001
Figure 1. Receiver operator characteristic (ROC) curves of the laboratory parameters (bilirubin, alkaline phosphatase, CA19-9) for
predicting the nature of the hilar biliary stricture.
Table II. CT findings determining the nature of the stricture.
Characteristic
Benign
(n34)
Malignant
(n24) p value
Mass 3 (8.8%) 15 (62.5%) B0.001
Lymph node1 cm 5 (14.7%) 11 (45.8%) 0.009
Atrophy-hypertrophy 4 (11.7%) 8 (33.3%) 0.06
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group had histopathological diagnosis, while 14
patients in the benign group had a biopsy for
confirmation of the diagnosis. Twenty patients in the
benign group had post-cholecystectomy benign biliary
stricture (BBS), and the surgical findings revealed no
mass, hence no biopsy of the bile duct was taken. All
these patients are on follow-up and are doing well.
Of 58 patients, 47 were operated and 11 were
managed using ERCP/PTC-guided intervention
(Table V). Of the 34 patients with a benign aetiology,
32 underwent a surgical procedure while 2 patients
were managed conservatively with stenting and anti-
tubercular therapy. A histological diagnosis was ob-
tained in both the latter patients by ERCP brush
cytology and bile examination was done for demon-
stration of acid-fast bacilli. Fifteen patients in the
malignant group underwent surgery while nine were
stented. Of the 15 patients, 10 patients underwent
curative resection and 7 of these had a frozen section
done. Two patients in the malignant group and one
patient in the benign group died. Both patients in the
malignant group died of septic complications while
the patient in the benign group died of aspiration.
Comparison of operative findings with imaging (Table VI)
Of the 32 patients in the benign group who underwent
surgery, 3 patients had a mass during surgery similar
to the findings on CT and MRCP and were treated as
a presumed malignant lesion, but the final post-
operative histopathology was suggestive of an inflam-
matory lesion in 2 patients and tuberculosis in 1
patient. Enlarged lymph nodes were seen in eight
patients at surgery as compared to five patients on
CT. The presence of atrophy-hypertrophy complex at
surgery was in concordance with CT and MRCP. The
confluence was patent in 25 patients at surgery as
compared to 23 patients on MRCP.
Of the 15 patients in the malignant group who
underwent surgery, a mass was seen in all patients
during surgery, but only 11 of these patients were
suspected to have a mass on CT and MRCP. Lymph
nodes were found to be present in 14 patients at
surgery, while CT detected lymph nodes in only 7 of
them. The presence of atrophy-hypertrophy complex
at surgery was in concordance with CT and MRCP.
However, the vascular involvement was present in
eight patients at surgery but detected in only three
patients on CT. Of these eight patients, three patients
underwent a curative resection, another three had a
Figure 2. (a) CT showing dilated common bile duct at porta (arrow) with no mass suggestive of benign stricture. Final diagnosis: benign
biliary stricture. (b) CT showing mass encasing left hepatic artery (arrow) with confluence block suggestive of Klatskin tumour. Final
diagnosis: cholangiocarcinoma. (c) CT showing mass (arrow) involving confluence with dilated intrahepatic biliary radicles suggestive of a
malignant stricture. Final diagnosis: cholangiocarcinoma.
Table III. MRI/MRCP characteristics determining the nature of
stricture.
Characteristic
Benign
(n34)
Malignant
(n24) p value
Mass 3 (8.8%) 16 (66.6%) B0.001
Irregular margin 4 (11.7%) 21 (87.5%) B0.001
Asymmetry 4 (11.7%) 20 (83.3%) B0.001
Abrupt cut-off 28 (82.3%) 18 (75%) 0.793
Length of stricture (cm) 1.290.6 3.091 B0.001
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palliative bypass and the remaining two patients had
laparotomy, biopsy and closure.
Of the nine patients considered unresectable, five
had vascular involvement (main portal vein), two had
type 4 stricture and two developed septic complica-
tions following preoperative biliary drainage. Five
patients were treated with bilateral PTBD and four
patients had bilateral endoscopic drainage. Two
Figure 4. MRCP projectional image showing stricture at conflu-
ence with abrupt cut-off and smooth margins (arrow) suggestive of
benign stricture. Final diagnosis: benign biliary stricture.
Figure 3. (a) MRI T2-weighted axial image showing hypointense mass lesion (arrow) at confluence suggestive of a malignant aetiology.
Final diagnosis: cholangiocarcinoma. (b) MRCP projectional image showing separation of right and left ducts at the confluence (arrow) and
irregular margins suggestive of a malignant stricture. Final diagnosis: cholangiocarcinoma. (c) MRCP projectional image showing stricture
just below confluence with irregular margins (arrow) suggestive of a malignant stricture. Final diagnosis: cholangiocarcinoma.
Figure 5. MRCP projectional image shows a calculus in gall
bladder neck (bold arrow) compressing the common hepatic duct
and causing proximal biliary dilatation suggestive of Mirizzi
syndrome. Final diagnosis: Mirizzi syndrome.
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patients had metallic stents and the rest had plastic
stents placed. Those who had a block just at the
confluence with a patent secondary confluence had
endoscopic drainage while the others were treated by
the percutaneous route. Two patients in each group
had cholangitis.
Follow-up
The mean follow-up of operated patients was 13.3
months (230 months) and for those who were
stented it was 4.1 months (112 months) in the
malignant group. On follow-up three patients died,
one had cholangitis, two developed anastomotic
stricture, two had local recurrence, two had systemic
recurrence, two are doing well and one was lost to
follow-up in the operated group. Seven of the nine
stented patients died while two were lost to follow-up.
Patients with anastomotic stricture were treated
with percutaneous balloon dilatation and are on
follow-up.
The mean follow-up of patients in the benign group
was 10 months (630 months). On follow-up both
patients with tubercular stricture treated with stenting
and ATT were doing well. The stent was removed in
one while the other was still stented. Two patients
who had secondary biliary cirrhosis had developed
ascites and were managed with diuretics. All the
others are doing well.
Discussion
Obstructive jaundice due to hilar biliary strictures can
be a diagnostic dilemma, as preoperative differentia-
tion between hilar cholangiocarcinoma and benign
biliary stricture is often difficult. We carried out a
prospective study using laboratory and imaging tests
to differentiate benign and malignant strictures.
In our study the patients with a malignant stricture
were older than patients in the benign group. Similar
results have been reported in the literature [21],
except for a retrospective study by Kim et al. [13] in
which they found that patients with both benign and
malignant strictures belonged to similar age groups.
In our study, the female preponderance in the benign
group was due to a high incidence of post-cholecys-
tectomy biliary strictures.
The clinical history and examination along with
biochemical parameters and tumour markers were
useful in arriving at a working diagnosis. The combi-
nation of painless progressive jaundice with weight
loss and anorexia is thought to be highly suspicious of
malignancy [7]. In our study we found anorexia and
weight loss to be significantly more common in
patients with malignant strictures. The incidence of
pain was similar in both groups. Previous biliary
surgery was an important factor in determining the
nature of the lesion, as iatrogenic bile duct injury is
the most common cause of benign strictures. In our
study all patients who had a history of previous biliary
surgery had had a cholecystectomy. Of 34 patients
who had a past history of cholecystectomy, 27 had a
benign stricture and 7 had a malignant stricture.
We found that a bilirubin level8.4 mg/dl and
alkaline phosphatase levels478 IU/L were sugges-
tive of a malignant lesion. Similar results have been
reported by Al-mofleh et al. [21], Pasanen et al. [22]
and Bain et al. [23]. As malignant lesions tend to have
complete obstruction, these patients tend to have
higher levels of bilirubin and alkaline phosphatase.
However, similar values may be present in benign
strictures in the presence of cholangitis or a long
history, thereby decreasing the specificity of these two
parameters.
The CA19-9 level is useful in diagnosing cholan-
giocarcinoma [2427]. In our study, a CA19-9
level100 U/L had a sensitivity of 45.5% and
Table IV. Aetiology of biliary strictures (n58).
Benign n (%) Malignant n (%)
Post-cholecystectomy 27 (79.5) Cholangiocarcinoma 21 (87.5)
Mirizzi syndrome 3 (8.8) Carcinoma
gall bladder
3 (12.5)
Tuberculosis 3 (8.8)
Inflammatory 1 (2.9)
Total 34 Total 24
Table V. Surgical and interventional procedures undertaken.
Procedures
Benign
(n34)
Malignant
(n24)
HJ 25 
CholecystectomyHJ 2 
Hemi-hepatectomyCBD excisionHJ 2 3
CholecystectomyCBD excisionHJ 1 
Cholecystectomycholedochoplasty 1 
CBD excisionWhipple’s procedure 1 1
Central hepatectomycholangiojejunostomy  2
CBD excisionHJ  4
Exploratory laparotomybiopsy  3
Segment 3 bypass  2
Endoscopic stenting 1 4
Percutaneous stenting 1 5
CBD, common bile duct; HJ, hepaticojejunostomy.
Table VI. Comparison of operative findings with CT and MRCP in
both groups.
Benign stricture Malignant stricture
Characteristic CT MRCP Surgery CT MRCP Surgery
Mass 3 3 3 11 11 15
Lymph node 5 NA 8 7 NA 14
Atrophy/hypertrophy
complex
4 4 4 8 8 8
NA, not applicable.
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specificity of 88% in predicting the malignant stric-
tures. These are comparable to the values reported in
the literature [11,24]. The level of CA19-9 could be
elevated in a variety of benign conditions, especially in
patients with obstructive jaundice, thereby decreasing
its specificity. Biliary obstruction and cholangitis can
result in high serum levels of CA19-9 thereby
decreasing its predictive value [28]. Relief of jaundice
decreases the serum levels to normal in benign
conditions but not in the malignant group. Therefore,
a repeat assay of CA19-9, 23 weeks after relief of
jaundice, may help in differentiating malignant stric-
tures from benign [11]. Biliary CA19-9 levels are not
of much diagnostic value, as the levels are raised in
both benign and malignant conditions [10].
Imaging remains the cornerstone for the evaluation
of the level of biliary obstruction and its underlying
cause. In this study, ultrasound correctly determined
the level of obstruction in all cases but the patency of
the confluence was assessed correctly in 96% of cases.
The accuracy of ultrasound to determine the level of
obstruction varies between 80% and 100% according
to the literature [28,29]. Non-union of the right and
left hepatic ducts, dilated intrahepatic biliary radicles
and/or the presence of a mass at the hilum suggest a
malignant aetiology. Variable sensitivities for detection
of a mass have been reported based on the morphol-
ogy of the stricture [28,29].
In our study CT had a sensitivity, specificity,
positive predictive value, negative predictive value
and diagnostic accuracy of 79.2%, 79.4%, 73.1%,
84.4% and 79.3%, respectively, for predicting the
nature of the stricture. Rosch et al. [12] found a
sensitivity and a specificity of 77% and 63%, respec-
tively, for CT to differentiate between benign and
malignant strictures. The presence of a mass (62.5%)
and lymph node enlargement1 cm (45.4%) were
significant (pB0.001 and 0.009, respectively) find-
ings in determining the malignant nature of the
stricture. Han et al. [30] found a mass with hyper-
enhancement in 17 of 21 patients with hilar cholan-
giocarcinoma. Choi et al. [31], in a retrospective
analysis, found a wall thickening1.5 mm suggestive
of a mass, rim-like contrast enhancement in either the
arterial or portal phase (60%), long stricture (1.8 cm
vs 0.7 cm), higher proximal dilatation (2.2 cm vs 1.8
cm) and lymph node enlargement1 cm as signifi-
cant findings on multiphasic spiral CT to diagnose a
malignant stricture.
We found that MRCP could demonstrate the level
of obstruction correctly in all cases. MRCP with MRI
had a sensitivity of 87.5%, specificity of 85.3%,
positive predictive value of 80.8%, negative predictive
value of 90.6% and diagnostic accuracy of 82.7% in
predicting the nature of the stricture. MRCP/MRI
can determine the level of obstruction in 85100% of
cases [32], while the sensitivity of differentiation of
benign from malignant strictures varied widely from
30% to 98% in the literature [13,33,34]. Park et al.
[35] found a sensitivity, specificity and accuracy of
81%, 70% and 76%, respectively, for MRCP/MRI to
differentiate between benign and malignant stricture.
The criteria for differentiation were based on the
findings observed during direct cholangiography and
included an irregular margin, asymmetric dilatation
of the biliary radicles, abrupt or gradual tapering of
stricture, presence or absence of a mass and length of
the stricture. Malignant strictures are usually long as
they have an infiltrative growth pattern, which spreads
intramurally beneath the epithelial lining. They are
irregular with an asymmetric dilatation because of the
nature of involvement of the bile duct by the tumour.
We found that presence of a mass, stricture with long
length (3 cm vs 1.2 cm) and an irregular margin and
asymmetric dilatation of the bile ducts helped in
making a diagnosis of a malignant stricture. Park
et al. [35] found stricture length (3 cm vs 1.3 cm) with
irregular margin and asymmetric narrowing of bile
ducts to suggest a malignant aetiology. Bain et al. [22]
found long stricture (3 cm vs 0.8 cm) and presence of
intrahepatic duct dilatation (93% vs 36%) to suggest a
malignant aetiology. The sensitivity of MRCP de-
creases in patients with a history of previous biliary
intervention and cholangitis, as there is inflammatory
thickening of the bile ducts and surrounding tissue,
which can mimic a mass or produce bile duct wall
enhancement on imaging.
Most of the previous studies done to evaluate the
role of MRCP in differentiation of hilar strictures have
used ERCP as the reference method [12,35,36]. We
have compared the imaging modalities with surgical
findings and biopsy in all operable cases and histo-
pathological diagnosis by tissue sampling under ultra-
sound guidance or during ERCP/PTC in inoperable
cases. Another drawback of these previous studies was
that both lower and upper end strictures were
evaluated together and a majority of the evaluated
patients had lower end strictures [12,35,36]. We have
analysed only hilar blocks, which makes our cohort
homogenous.
Kim et al. [13], using conventional T1- and T2-
weighted images and gadolinium-enhanced dynamic
MR images, found that non-enhanced T1 and less
heavily T2-weighted images with MRCP significantly
improved the diagnostic accuracy, while gadolinium-
enhanced images did not further improve the accu-
racy. We also looked at T1 and T2 images while
interpreting the results of MRCP primarily to detect
the presence of a mass.
Domagk et al. [36] showed that intraductal US can
help in distinguishing malignant from benign stric-
tures by demonstrating a heterogeneous and irregular
bile duct thickening and invasion of the portal vein or
hepatic artery on imaging. Klatskin tumours are
small, fibrotic and hypocellular, resulting in false
negative results and at times lesions may not be
accessible at all. Preoperative brush cytology/bio-
psy, digital imaging analysis and fluorescent in situ
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hybridization has sensitivity between 30% and 60%
[37,38]. The role of frozen section analysis is also
limited, as well-differentiated cholangiocarcinoma are
difficult to differentiate from benign lesions with the
small amount of tissue obtained during surgery.
Moreover it has a definite potential for implantation
metastasis.
We conclude that although it is difficult to differ-
entiate a benign biliary stricture from a malignant one
preoperatively, it is possible to identify them with the
help of laboratory parameters and imaging with
reasonable accuracy. Malignant strictures are more
common in patients with age more than 50 years and
those with a history of anorexia and weight loss.
Patients with bilirubin level8.4 mg/dl and CA19-
9100 U/ml are more likely to have a malignant
aetiology. MRI with MRCP has higher sensitivity and
specificity rates than CECT. It is better than CT as it
can provide a detailed map of the biliary tree above
the stricture, which is helpful in formulating both
surgical and interventional management in these
patients. Overall, MRI with MRCP was the best
modality for predicting the nature of hilar biliary
stricture.
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